{"podcast":{"title":"Cell & Gene: The Podcast","slug":"cell-gene-the-podcast-4048431","podcast_index_feed_id":4048431,"rss_url":"https://rss.buzzsprout.com/1810482.rss","website_url":"https://www.buzzsprout.com/1810482","image_url":"https://storage.buzzsprout.com/f3p8rfd9kizh4zywm5msg5goq7nu?.jpg","author":"Erin Harris","episode_count":140,"summary":"Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.","last_synced_at":"2026-06-18T18:19:19.741610+00:00","page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431"},"episode":{"title":"Building Safer CRISPR Medicines for CVD with Scribe Therapeutics' Benjamin Oakes","slug":"building-safer-crispr-medicines-for-cvd-with-scribe-therapeutics-benjamin-oakes","published_at":"2026-01-29T11:00:00+00:00","page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431/building-safer-crispr-medicines-for-cvd-with-scribe-therapeutics-benjamin-oakes","show_page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431","url":"https://www.buzzsprout.com/1810482/episodes/18570523-building-safer-crispr-medicines-for-cvd-with-scribe-therapeutics-benjamin-oakes.mp3","audio_url":"https://www.buzzsprout.com/1810482/episodes/18570523-building-safer-crispr-medicines-for-cvd-with-scribe-therapeutics-benjamin-oakes.mp3","summary":"We love to hear from our listeners. Send us a message. In episode 121 of Cell & Gene: The Podcast, Host Erin Harris talks to Scribe Therapeutics' CEO and Co-Founder Benjamin Oakes about building next‑generation CRISPR and epigenetic editing tools to move genetic medicine beyond rare disease into common cardiometabolic indications. Oakes shares Scribe’s engineered CasX platform and epigenetic silencers, preclinical data from its various programs, and why exquisite specificity and low-dose ...","meta_description":"We love to hear from our listeners. Send us a message. In episode 121 of Cell & Gene: The Podcast, Host Erin Harris talks to Scribe Therapeutics' CEO…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1803,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/building-safer-crispr-medicines-for-cvd-with-scribe-therapeutics-benjamin-oakes/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431/building-safer-crispr-medicines-for-cvd-with-scribe-therapeutics-benjamin-oakes.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}